تحريض المخاض باستخدام الميزوبروستول في تمام الحمل
Abstract
شملت الدراسة 100 مريضة قسمت إلى مجموعتين :
الأولى 50 مريضة تم إعطاؤها الميزوبروستول 25 مكغ مهبليا" كل أربع ساعات .
الثانية 50 مريضة تم إعطاؤها الاوكسيتوسين وجاءت النتائج كالآتي :
إن للبروستاغلاندينات E1 دورا" بالغ الأهمية في إنضاج عنق الرحم وتحريض المخاض.
فترة التحريض 2.5- 28ساعة في المجموعة الأولى6-24.5 ساعة في المجموعة الثانية أي بمعدل
15.25 ساعة في المجموعتين، نسبة نجاح التحريض 92% في المجموعة الأولى ,94% في المجموعة الثانية، نسبة القيصريات 10.8% في المجموعة الأولى و10.6% في المجموعة الثانية نسبة تألم الجنين 4.347% في المجموعة الأولى و4.25% في المجموعة الثانية ،نسبة نجاح التحريض عندما بيشوب 1-2 80% في المجموعة الأولى و60% في المجموعة الثانية، وبالتالي الميزوبروستول أكثر فعالية من الأوكسيتوسين عندما يكون العنق أقل نضجا"
The study included 100 patients who were divided into two groups:
Group 1 included 50 patients who were administered Misoprostol 25 mg vaginally every 4 hours. Group 2 included 50 patient who were prescribed Oxytocin.
The results were as follows:
- Prostaglandin E1 is an important factor for ripening cervix and inducing labor.
-The duration of induction is 2.5-28 hours in the first group and 6-24.5 hours in the second, and the incidence is 15,25 in both groups.
-The rate of induction success is 92 % in the first group and 94% in the second.
-The rate of cesarean section is 10.8 % in the first group and 10.6% in the second.
-The rate of fetal distress is 4.347% in the first group and 4.25% in the second.
- When Bishopped 1-2, the rate of induction success 80% in the first group and 60% in the second. This means that Misoprostol is more effective than Oxytocin when the cervix uterine is not ripe .
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.